Skip to main content
SpringerLink
Log in

Pain in Hematologic Malignancies

  • Chapter
  • First Online:
Essentials of Interventional Cancer Pain Management

  • 1584 Accesses

Abstract

Hematologic malignancies (HTM) or blood-related cancers (BRC) include leukemia (acute or chronic), lymphomas, and plasma cell disorders. HTM are generally less common than solid tumors, but can be associated with substantial symptom burden, including several pain syndromes, some of which are unique to these conditions. During the course of HTM, pain can be induced by the disease itself, by the diagnostic procedures, or by the different treatment modalities. Pain can also occur from disease-associated complications, secondary to iatrogenic causes, or even at times may be due to unrelated clinical conditions.

In patients with BRC, pain may be the presenting symptom at disease onset, and this kind of pain generally responds with initiation of treatment. Patients under active treatment can report iatrogenic pains of short or long duration. Survivors on the other hand can experience chronic pain due to treatment-related complication or residual post treatment of the disease itself. In patients with advanced, incurable/refractory disease distressing pain symptoms should be managed in context of comprehensive end of life care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Niscola P, et al. Pain syndromes in hematologic malignancies: an overview. Hematol J. 2004;5:293–303.

    Article  Google Scholar 

  2. Niscola P, et al. Pain in blood cancers. Indian J Palliat Care. 2011;17(3):175–83.

    Article  Google Scholar 

  3. Roodman, GD. Mechanisms of bone lesions in myeloma and lymphoma. Cancer. 1997;80(8):1557–63.

    Article  CAS  Google Scholar 

  4. Pathogenesis and Management of Myeloma Bone Disease. Christoulas, et al. Expert Rev Hematol. 2009;2(4):385–98.

    Article  Google Scholar 

  5. Khan OA, et al. Vertebral augmentation in patients with multiple myeloma: a pooled analysis of published case series. Am J Neuroradiol. 2014;35:207–10.

    Article  CAS  Google Scholar 

  6. Kubista E, Glaspy J, Holmes FA, Green MD, Hackett J, Neumann T, Pegfilgrastim Study Group. Bone pain associated with once-per-cycle pegfilgrastim is similar to daily filgrastim in patients with breast cancer. Clin Breast Cancer. 2003;3(6):391–8.

    Article  CAS  Google Scholar 

  7. Pawloski PA, Larsen M, Thoresen A, Giordana MD. Pegfilgrastim use and bone pain: a cohort study of community-based cancer patients. J Oncol Pharm Pract. 2015 May 7. pii: 1078155215585188. [Epub ahead of print].

    Google Scholar 

  8. Xu H, Gong Q, Vogl FD, Reiner M, Page JH. Risk factors for bone pain among patients with cancer receiving myelosuppressive chemotherapy and pegfilgrastim. Support Care Cancer. 2016;24(2):723–30. https://doi.org/10.1007/s00520-015-2834-2. Epub 2015 Jul 11.

    Article  CAS  PubMed  Google Scholar 

  9. Kirshner JJ, Heckler CE, Janelsins MC, Dakhil SR, Hopkins JO, Coles C, Morrow GR. Prevention of pegfilgrastim-induced bone pain: a phase iii double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical commun oncol program research base. J Clin Oncol. 2012;30(16):1974–9. https://doi.org/10.1200/JCO.2011.37.8364. Epub 2012 Apr 16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Moukharskaya J, Abrams DM, Ashikaga T, Khan F, Schwartz J, Wilson K, Verschraegen C, Openshaw T, Valentine J, Eneman J, Unger P, Ades S. Randomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastim. Support Care Cancer. 2016 Feb 19. [Epub ahead of print].

    Google Scholar 

  11. Visani G, Bontempo G, Manfroi S, Pazzaglia A, D’Alessandro R, Tura S. All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: a possible disease association. Haematologica. 1996;81(2):152–4. Review.

    CAS  PubMed  Google Scholar 

  12. Visani G, Bontempo G, Manfroi S, Pazzaglia A, D’Alessandro R, Tura S. All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: a possible disease association. Haematologica. 1996;81(2):152–4.

    CAS  PubMed  Google Scholar 

  13. Guirgis MF, Lueder GT. Intracranial hypertension secondary to all-trans retinoic acid treatment for leukemia: diagnosis and management. J AAPOS. 2003;7(6):432–4.

    Article  Google Scholar 

  14. Decaudin D, Adams D, Naccache P, Castagna L, Munck JN. Maintained all-trans retinoic acid therapy in a patient with pseudotumour cerebri despite aggravated symptoms. Leuk Lymphoma. 1997;27(3–4):373–4.

    Article  CAS  Google Scholar 

  15. Jabbour E, O’Brien S, Kantarjian H, Garcia-Manero G, Ferrajoli A, Ravandi F, Cabanillas M, Thomas DA. Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia. Blood. 2007;109(8):3214–8. Epub 2007 Jan 5.

    Article  CAS  Google Scholar 

  16. Kantarjian HM, O’Brien S, Smith TL, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol. 2000;18:547–61.

    Article  CAS  Google Scholar 

  17. Kantarjian H, Thomas D, O’Brien S, et al. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer. 2004;101:2788–801.

    Article  CAS  Google Scholar 

  18. Thomas DA, O’Brien S, Cortes J, et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood. 2004;104:1624–30.

    Article  CAS  Google Scholar 

  19. Thomas DA, Faderl S, O’Brien S, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006;106:1569–80.

    Article  CAS  Google Scholar 

  20. Scott BJ, van Vugt VA, Rush T, Brown T, Chen CC, Carter BS, Schwab R, Fanta P, Helsten T, Bazhenova L, Parker B, Pingle S, Saria MG, Brown BD, Piccioni DE, Kesari S. Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study. J Neuro Oncol. 2014 Jun 19. [Epub ahead of print].

    Google Scholar 

  21. Chamberlain MC. Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series. J Neuro-Oncol. 2012;109(1):143–8. https://doi.org/10.1007/s11060-012-0880-x. Epub 2012 Apr 27.

    Article  CAS  Google Scholar 

  22. JLM J, et al. Chemotherapy induced peripheral neuropathies in hematological malignancies. J Neuro-Oncol. 2015;121(2):229–37.

    Article  Google Scholar 

  23. Sonneveld P, et al. Dealing with neuropathy in plasma-cell dyscrasias. ASH Education Book. 2010;2010(1):423–30.

    Google Scholar 

  24. Rison RA, et al. Paraproteinemic neuropathy: a practical review. BMC Neurol. 2016;16:13.

    Article  Google Scholar 

  25. Tran TN, et al. Complications of herpes zoster in cancer patients. Scand J Infect Dis. 2014;46(7):528–32.

    Article  Google Scholar 

  26. Wade J. Viral infections in patients with hematological malignancies. ASH Education Book. 2006;2006(1):368–74.

    Google Scholar 

  27. Niscola P, et al. Mucositis in patients with hematologic malignancies: an overview. Haematologica. 2007;92(2):222–31.

    Article  Google Scholar 

  28. Spielberger R, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004;351(25):2590–8.

    Article  CAS  Google Scholar 

  29. Niscola P, et al. Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies. Bone Marrow Transplant. 2008;41:757–64.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MD Anderson Cancer Center at Cooper, Department of Hematology/Oncology, Camden, NJ, USA

    Kanu Sharan

Authors
  1. Kanu Sharan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kanu Sharan .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology and Critical Care, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Amitabh Gulati

  2. Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Vinay Puttanniah

  3. Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, TX, USA

    Brian M. Bruel

  4. Midwest Neuroscience Institute, Center for the Relief of Pain, Kansas City, MO, USA

    William S. Rosenberg

  5. Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Joseph C. Hung

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sharan, K. (2019). Pain in Hematologic Malignancies. In: Gulati, A., Puttanniah, V., Bruel, B., Rosenberg, W., Hung, J. (eds) Essentials of Interventional Cancer Pain Management. Springer, Cham. https://doi.org/10.1007/978-3-319-99684-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-99684-4_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-99682-0

  • Online ISBN: 978-3-319-99684-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation